Matthew M. Walsh - Feb 20, 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol
OGN
Transactions as of
Feb 20, 2025
Transactions value $
-$188,250
Form type
4
Date filed
2/24/2025, 05:09 PM
Previous filing
Sep 5, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Award $0 +30.4K +33.07% $0.00 122K Feb 20, 2025 Direct F1
transaction OGN Common Stock Tax liability -$159K -10.7K -8.71% $14.92 112K Feb 20, 2025 Direct
transaction OGN Common Stock Award $0 +5.57K +4.99% $0.00 117K Feb 20, 2025 Direct F2
transaction OGN Common Stock Tax liability -$29.2K -1.91K -1.63% $15.29 115K Feb 20, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
F2 Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.